Cargando…

Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody

Progressing tumors in man and mouse are often infiltrated by dendritic cells (DCs). Deficient antitumor immunity could be related to a lack of tumor-associated antigen (TAA) presentation by tumor-infiltrating DCs (TIDCs) or to a functional defect of TIDCs. Here we investigated the phenotype and func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vicari, Alain P., Chiodoni, Claudia, Vaure, Céline, Aït-Yahia, Smina, Dercamp, Christophe, Matsos, Fabien, Reynard, Olivier, Taverne, Catherine, Merle, Philippe, Colombo, Mario P., O'Garra, Anne, Trinchieri, Giorgio, Caux, Christophe
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2002
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196048/ https://www.ncbi.nlm.nih.gov/pubmed/12186845 http://dx.doi.org/10.1084/jem.20020732

Ejemplares similares

Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites
por: Dieu, Marie-Caroline, et al.
Publicado: (1998)

Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG Oligonucleotide
por: Smolianov, Vsevolod, et al.
Publicado: (2011)

Type I interferon dependence of plasmacytoid dendritic cell activation and migration
por: Asselin-Paturel, Carine, et al.
Publicado: (2005)

Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
por: Hanagata, Nobutaka
Publicado: (2012)

Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy**
por: Liu, Haipeng, et al.
Publicado: (2011)

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
por: Buss, Colin G., et al.
Publicado: (2020)

Synthetic double-stranded RNA oligonucleotides are immunostimulatory for chicken spleen cells
por: Villanueva, A.I., et al.
Publicado: (2011)

PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56(+) (NK and NKT) Cells
por: Rodriguez, Juan M., et al.
Publicado: (2015)

Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
por: Lai, Chao-Yang, et al.
Publicado: (2019)

CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015)

Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers
por: Cooper, Curtis L, et al.
Publicado: (2008)

Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells
por: Du, Hai-yan, et al.
Publicado: (2007)

Enhancement of the Immunostimulatory Effect of Phosphodiester CpG Oligodeoxynucleotides by an Antiparallel Guanine-Quadruplex Structural Scaffold
por: Safitri, Fika Ayu, et al.
Publicado: (2021)

The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018)

Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists
por: Meng, Wenjun, et al.
Publicado: (2011)

Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides
por: Zhang, Huijie, et al.
Publicado: (2015)

Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2017)

Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use
por: Aoshi, Taiki, et al.
Publicado: (2015)

A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo
por: Li, Tete, et al.
Publicado: (2020)

Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences
por: Chuang, Yu-Chen, et al.
Publicado: (2020)

Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs
por: Grajkowski, Andrzej, et al.
Publicado: (2005)

DEC-205 is a cell surface receptor for CpG oligonucleotides
por: Caminschi, Irina, et al.
Publicado: (2013)

Flexibility of Mouse Classical and Plasmacytoid-derived Dendritic Cells in Directing T Helper Type 1 and 2 Cell Development: Dependency on Antigen Dose and Differential Toll-like Receptor Ligation
por: Boonstra, André, et al.
Publicado: (2003)

Assessment of immunostimulatory responses to the antimiR-22 oligonucleotide compound RES-010 in human peripheral blood mononuclear cells
por: Panella, Riccardo, et al.
Publicado: (2023)

Publisher Correction: Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2018)

Publisher Correction: Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2018)

Targeted Delivery of Immunostimulatory CpG Oligodeoxynucleotides to Antigen-Presenting Cells in Draining Lymph Nodes by Stearic Acid Modification and Nanostructurization
por: Nagaoka, Makoto, et al.
Publicado: (2022)

Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
por: Kayraklioglu, Neslihan, et al.
Publicado: (2017)

Functional Downregulation of PD-L1 and PD-L2 by CpG and non-CpG Oligonucleotides in Melanoma Cells
por: Kleemann, Johannes, et al.
Publicado: (2022)

The Development of Murine Plasmacytoid Dendritic Cell Precursors Is Differentially Regulated by FLT3-ligand and Granulocyte/Macrophage Colony-Stimulating Factor
por: Gilliet, Michel, et al.
Publicado: (2002)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction
por: Hessel, Edith M., et al.
Publicado: (2005)

Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotides
por: Bertoni, Carmen, et al.
Publicado: (2009)

The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy
por: Kinjo, Takeshi, et al.
Publicado: (2012)

The Inducible CXCR3 Ligands Control Plasmacytoid Dendritic Cell Responsiveness to the Constitutive Chemokine Stromal Cell–derived Factor 1 (SDF-1)/CXCL12
por: Vanbervliet, Béatrice, et al.
Publicado: (2003)

Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2013)

CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
por: Knuefermann, Pascal, et al.
Publicado: (2007)

Regulating the regulator: Bhlhe40 directly keeps IL-10 in check
por: Gabryšová, Leona, et al.
Publicado: (2018)

Willingness to reduce travel consumption to support a low-carbon transition beyond COVID-19
por: O'Garra, Tanya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6jlic3tr01p8nphdpviioc87va